Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Dixon H. B., Gibbs K., Walshe J. M. Preparation of triethylenetetramine dihydrochloride for the treatment of Wilson's disease. Lancet. 1972 Apr 15;1(7755):853–853. doi: 10.1016/s0140-6736(72)90845-8. [DOI] [PubMed] [Google Scholar]
- Gibbs K., Walshe J. M. Penicillamine and pyridoxine requirements in man. Lancet. 1966 Jan 22;1(7430):175–179. doi: 10.1016/s0140-6736(66)90700-8. [DOI] [PubMed] [Google Scholar]
- JAFFE I. A., ALTMAN K., MERRYMAN P. THE ANTIPYRIDOXINE EFFECT OF PENICILLAMINE IN MAN. J Clin Invest. 1964 Oct;43:1869–1873. doi: 10.1172/JCI105060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sternlieb I., Van den Hamer C. J., Morell A. G., Alpert S., Gregoriadis G., Scheinberg I. H. Lysosomal defect of hepatic copper excretion in Wilson's disease (hepatolenticular degeneration). Gastroenterology. 1973 Jan;64(1):99–105. [PubMed] [Google Scholar]
- Walshe J. M. The physiology of copper in man and its relation to Wilson's disease. Brain. 1967 Mar;90(1):149–176. doi: 10.1093/brain/90.1.149. [DOI] [PubMed] [Google Scholar]